Vascular News and Research

RSS
New guidelines on the management of antithrombotic agents for endoscopic procedures published

New guidelines on the management of antithrombotic agents for endoscopic procedures published

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

University of Texas launches phase II clinical trial to test stem-cell-based therapy on injured heart muscle

University of Texas launches phase II clinical trial to test stem-cell-based therapy on injured heart muscle

Dr. Brian Newman to conduct two training sessions for medical professionals on Veinwave system

Dr. Brian Newman to conduct two training sessions for medical professionals on Veinwave system

Baylor Jack and Jane Hamilton Heart and Vascular Hospital receives AACVPR Innovation Award

Baylor Jack and Jane Hamilton Heart and Vascular Hospital receives AACVPR Innovation Award

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Study: Besides nerves, skin has a unique sensory system

Study: Besides nerves, skin has a unique sensory system

Non-clinical data of CK-2017357 presented by Cytokinetics

Non-clinical data of CK-2017357 presented by Cytokinetics

iRGD peptide found to enhance both cancer detection and treatment

iRGD peptide found to enhance both cancer detection and treatment

SonoSite launches new portable and compact ultrasound system in Europe

SonoSite launches new portable and compact ultrasound system in Europe

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

Discovery presents a vital step towards efficient treatment of vascular injuries

Discovery presents a vital step towards efficient treatment of vascular injuries

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Biotechnology Consulting Poland applies to the EU for structural and cohesion funding

Biotechnology Consulting Poland applies to the EU for structural and cohesion funding

Free health clinic offers preventive primary care for uninsured residents of Kansas City

Free health clinic offers preventive primary care for uninsured residents of Kansas City

Axsun Technologies reports successful testing of novel OCT imaging integrated light source architecture

Axsun Technologies reports successful testing of novel OCT imaging integrated light source architecture

Risk of having a potentially fatal blood clot after surgery is higher, finds research

Risk of having a potentially fatal blood clot after surgery is higher, finds research

New tool may allow doctors to predict long-term survival rates of dialysis patients

New tool may allow doctors to predict long-term survival rates of dialysis patients

NHLBI awards new federal grant to improve the quality of stored transfusion blood

NHLBI awards new federal grant to improve the quality of stored transfusion blood

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.